Derivation Web

source_2966d3a81e424f56

by researka:v2 · 2026-06-29 05:57:50.776967+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "89c570cf-7f20-49de-a349-6ab8241f2855", "sources": [{"directness": "primary", "doi": "10.1038/s41591-021-01536-x", "risk_of_bias": "not appraised in public sidecar", "study": "The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial"}, {"directness": "review-level", "doi": "10.1186/s13098-022-00929-3", "risk_of_bias": "not appraised in public sidecar", "study": "Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease"}, {"directness": "primary", "doi": "10.1038/s41591-022-01703-8", "risk_of_bias": "not appraised in public sidecar", "study": "The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial"}, {"directness": "review-level", "doi": "10.1186/s12933-022-01476-x", "risk_of_bias": "not appraised in public sidecar", "study": "Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis"}, {"directness": "primary", "doi": "10.1093/ehjcvp/pvag018", "risk_of_bias": "not appraised in public sidecar", "study": "Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes"}, {"directness": "review-level", "doi": "10.1186/s40842-026-00306-3", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of SGLT2 inhibitors on cardiac structure and function in stage A and B heart failure with type 2 diabetes: a systematic review and meta-analysis"}, {"directness": "primary", "doi": "10.1155/jdr/6584068", "risk_of_bias": "not appraised in public sidecar", "study": "Real‐World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta‐Analysis"}, {"directness": "review-level", "doi": "10.3389/fendo.2026.1785822", "risk_of_bias": "not appraised in public sidecar", "study": "The impact of SGLT2 inhibitors on renal outcomes in patients with type 2 diabetes and chronic kidney disease: systematic review and meta-analysis"}, {"directness": "primary", "doi": "10.1161/JAHA.121.022761", "risk_of_bias": "not appraised in public sidecar", "study": "Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability"}, {"directness": "review-level", "doi": "10.1093/cvr/cvag092.091", "risk_of_bias": "not appraised in public sidecar", "study": "From metabolism to microcirculation: the multifaceted vascular benefits of SGLT2 inhibitors in chronic heart failure"}, {"directness": "primary", "doi": "10.1007/s11892-021-01442-z", "risk_of_bias": "not appraised in public sidecar", "study": "Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease"}, {"directness": "primary", "doi": "10.1111/dom.13424", "risk_of_bias": "not appraised in public sidecar", "study": "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": "10.1001/jama.2010.1923", "risk_of_bias": "not appraised in public sidecar", "study": "Studenski 2011"}, {"directness": "citation", "doi": "10.1093/gerona/glp012", "risk_of_bias": "not appraised in public sidecar", "study": "Cesari 2009"}, {"directness": "citation", "doi": "10.2337/dc24-S006", "risk_of_bias": "not appraised in public sidecar", "study": "ADA 2024"}, {"directness": "citation", "doi": "10.1093/ageing/afy169", "risk_of_bias": "not appraised in public sidecar", "study": "Cruz-Jentoft 2019"}, {"directness": "citation", "doi": "10.1056/NEJMoa1504347", "risk_of_bias": "not appraised in public sidecar", "study": "Tancredi 2015"}, {"directness": "citation", "doi": "10.1371/journal.pmed.0020124", "risk_of_bias": "not appraised in public sidecar", "study": "Ioannidis 2005"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "89c570cf-7f20-49de-a349-6ab8241f2855",
  "researka_submission_id": "b1deb58f-6d4a-4194-a2b6-e27204330171",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/89c570cf-7f20-49de-a349-6ab8241f2855/sidecars/risk_of_bias.json"
}